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Introduction 
 
There is substantial evidence that cognitive behaviour therapy (CBT) and several other 
psychological therapies are effective treatments for depression and/or anxiety disorders. 
Starting in 2004 the National Institute of Health and Care Excellence (NICE) conducted 
systematic reviews of research on the efficacy of interventions for depression and anxiety 
disorders. The reviews led to the publication of a series of clinical guidelines that advocate 
the use of specific forms of CBT for depression and all the anxiety disorders (NICE 2004a, 
2004b, 2005a, 2005b, 2006, 2009a, 2009b, 2011, 2013.) Some other therapies (interpersonal 
psychotherapy, behavioural couples therapy, counseling, brief dynamic therapy) are also 
recommended (with varying indications) for depression, but not for anxiety disorders. 
Surveys of patients suggest that approximately twice as many patients have a preference for 
psychological treatment compared to medication (Kwan, Dimidjian and Rizvi, 2010). 
However, only a small fraction of people in the community with common mental health 
disorders were ever offered an evidence-based psychological treatment (McManus and 
Bebbington, 2009). 
The English Improving Access to Psychological Therapies (IAPT) initiative was 
designed to address the need for much greater access to NICE recommended psychological 
therapies for depression and anxiety disorders (see Clark, 2011 for an overview of the 
programme and its history). Pilot work was undertaken in Newham and Doncaster (see Clark 
et al., 2009 for an evaluation) and a National Implementation Plan was published in early 
2008 (Department of Health, 2008). The plan covered a period of six years during which the 
number of IAPT services in the country would gradually increase until all areas had a local 
service. Each service was required to provide NICE recommended therapy. For mild to 
moderate depression and several anxiety disorders (but not PTSD or social anxiety disorder) 
NICE recommends a stepped care model of service provision in which a substantial 
proportion of individuals are first offered a low intensity intervention (such as guided self-
help), with individuals who fail to respond adequately to low intensity intervention being 
stepped up to more traditional face-to-face therapy (high intensity intervention). The IAPT 
services adopted this model when appropriate. Roll-out to at least 20 local services in 2008/9 
was agreed for the first year. Initial progress was greater than expected with 35 services being 
established in that year.  
Detailed outcome monitoring and ongoing evaluations of the programme are 
considered an integral part of IAPT. The programme stipulates a minimum dataset, which 
records the care provided to each service user and his or her clinical progress. High levels of 
pre-post data completeness are achieved by the use of a session-by-session outcome 
monitoring system that guarantees that a clinical endpoint is available even if a patient ends 
therapy earlier than expected. In July 2010, the North East Public Health Observatory 
published a report detailing an initial analysis of data taken from the first year of the IAPT 
programme (Glover, Webb and Evison, 2010). The report particularly focused on equity of 
access, descriptions of the treatments offered, gradings of staff and overall outcome. The 
report found that the overall recovery rate in the services was 42% for patients who received 
at least some treatment (defined as having at least 2 sessions on the assumption that the first 
session was always assessment). It was found that although the majority of patients received 
NICE compliant treatment for their disorder, a significant minority did not. However the 
analysis did not consider whether compliance with NICE guidance impacted on patient 
outcome. Significant between service variability in recovery rates was observed but 
predictors of this variability were also not investigated.  
A recent report (Department of Health, 2012) covering the first three years of IAPT 
showed that roll-out of the programme remained broadly on target. In the first three years 
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over 150 IAPT services were established and more than one million people used the new 
services with an overall recovery rate in excess of 45% for those people who had completed 
treatment. The recovery figures are approaching the programme’s 50% target, which is 
derived from the randomized controlled trials that generated the initial NICE 
recommendations (Department of Health, 2008). IAPT services’ recovery rates increased 
year on year, with the highest recovery rates observed in the most recent time period. This 
increase was also seen in the number of people leaving welfare support. As with the Glover 
report, the IAPT three-year report did not investigate predictors of variability in outcome.  
This present report takes a more detailed look at the year one IAPT data in order to 
identify predictors of variability in outcome at the patient level, at service level and as a 
function of compliance or deviation from NICE recommendations about the type of treatment 
that should be offered for a particular problem. The aim of this more detailed analysis is to 
learn lessons that can be implemented in the future to help routine clinical services enhance 
the outcomes that they achieve with their clientele.  
 
 
Methods 
 
Ethics statement 
This study is considered a routine service evaluation. Consent was obtained from both the 
Department of Health and the individual services for the data analysis. Each service obtained 
the consent of patients for their anonymised data to be included in the Minimum Data Set for 
subsequent analysis. 
 
Design 
An observational, prospective cohort design. Patients who were assessed by the services were 
asked to complete standardized measures of depression and anxiety at every session and other 
measures in the Minimum Data Set (MDS: Department of Health,2011) at less frequent 
intervals. 32 of the 35 Year One IAPT services provided data for analysis. The remaining 
services were still developing their information technology systems and were unable to 
participate in the analysis. The data were collected between 1
st
 October 2008 to 30
th
 
September 2009. Services varied in when they became operational. Eighteen services started 
collecting data in the first month, a further 10 started in the second month, the remainder 
started further into the year. 
 
Patients  
Up to 19,395 patients were included in the analyses. To be included they were required to 
satisfy a number of criteria (see Figure 1). Patients were required to have an initial 
assessment and to have completed their treatment by the end of September 2009 (i.e. at the 
end of the programme’s first year). This meant that a large proportion of patients who 
accessed the services in year one could not be included as they had not yet completed their 
treatment. Patients were also required to have been clinical cases at the initial assessment and 
to have received as least a minimal dose of therapy. Casesness was defined as scoring above 
clinical/non-clinical cut-off on the depression and/or anxiety measure. To be considered 
someone who had at least a minimal dose of therapy, patients had to have attended at least 
two sessions. This was because : 1) it was thought unlikely that patients who had only one 
session would have received a significant amount of treatment as the first session was almost 
always devoted to assessment; and 2) separate pre- and post-treatment PHQ-9 and GAD-7 
scores could not be collected if there was only one session. So that clinical change could be 
estimated patients had to have completed at least two PHQ-9 and GAD-7 questionnaires 
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during the course of their treatment. The percentage of treated patients that provided pairs of 
PHQ-9 and GAD-7 scores was unusually high for a routine cohort study. Among those who 
were seen at least twice and were clinical cases at initial assessment, 91.4% (20,009/21,882) 
had paired scores (see Figure 1). For some analyses, patients were also required to have been 
allocated an ICD-10 diagnosis by their service. NICE recommendations are diagnosis 
specific so it would not be possible to assess the impact of NICE compliance without this 
information. In addition, it seemed likely that overall outcome may vary with diagnosis. 
Finally, for some analyses patients were required to have been treated in a service that 
provided detailed information on the types of treatment that they received (three services 
were excluded for this reason, four services were excluded as they did not give patients’ 
diagnoses and one service did not indicate whether patients were still receiving treatment or 
not as patients were not given an end of treatment marker). Overall, data from 24 services 
were included in the analysis. 
 
Measures 
Depression was assessed with the 9-item Patient Health Questionnaire Depression Scale 
(PHQ-9: Kroenke, Spitzer and Williams, 2001) which ranges from 0 to 27 with a 
recommended cut-off of 10 or above for distinguishing between clinical and non-clinical 
populations. Anxiety was assessed with the 7-item Patient Health Questionnaire Generalized 
Anxiety Disorder Scale (GAD-7: (Spitzer, Kroenke, Williams and Lo, 2006), which ranges 
from 0 to 21. Although the latter scale was originally developed to screen for Generalised 
Anxiety Disorder (GAD), it also has satisfactory (albeit lower) sensitivity and specificity for 
detecting other anxiety disorders when a cut off of 8 or above is used (Kroenke, Spitzer, 
Williams, Monahan and Löwe, 2007).  
 
Outcome indices  
Previous reports of outcomes in IAPT services have used the “recovery” index. An individual 
is judged to have recovered if s/he is a case at pre-treatment and has dropped below the 
clinical/non-clinical cut-off for depression and anxiety at post-treatment. This measure does 
not take into account whether the observed change is greater than the measurement error of 
the scales. As a consequence, a patient who starts treatment just above the clinical threshold 
and finishes treatment just below it will be classified as “recovered” even if the improvement 
is not statistically reliable. To get round this problem, we used a “reliable recovery” index. 
Patients were deemed to have reliably recovered if they scored above the clinical cut-off on 
the PHQ-9 and/or the GAD-7 at initial assessment, they showed reliable improvement during 
treatment, and they scored below the clinical cut-offs on both the PHQ-9 and the GAD-7 at 
the end of treatment. Reliable improvement was assessed using Jacobson and Truax’s (1991) 
reliable change criteria. The measure of reliability used for the PHQ-9 and the GAD-7 was 
Cronbach’s α, taken from the validation studies of the measures (Kroenke et al., 2001; 
Spitzer et al., 2006). To be considered reliable, pre-post change on the PHQ-9 needed to 
exceed 5.20. For the GAD-7 the comparable value was 3.53. Patients were considered to 
have shown reliable improvement if their PHQ-9 or GAD-7 score reliably decreased and the 
score for the other scale either did the same or did not reliably deteriorate. For the main 
predictive analyses, we focus on the reliable recovery index as this most closely corresponds 
to the measure normally reported by IAPT services. However, we recognize that some 
patients may show worthwhile improvements in therapy that fall short of full recovery. To 
capture this phenomenon, we report reliable improvement rates. Similarly, some patients may 
deteriorate during a course of therapy. To capture this phenomenon, we also report reliable 
deterioration rates. Patients are considered to have shown reliable deterioration if their PHQ-
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9 or GAD-7 score reliably increased and the score for the other scale either did the same or 
did not reliably improve.  
 
Statistical analysis 
Logistic regression models were used to test whether compliance or deviation from NICE 
recommendations about the type of treatment that should be offered had an effect on patients’ 
likelihood for reliable recovery. These analyses controlled for patients’ initial scores on the 
PHQ-9 and the GAD-7 and, in the case of patients who received high intensity treatment, 
whether they had also received low intensity treatment prior to receiving high intensity 
treatment. A simultaneous entry method was used to control for the effects of the variables. 
NICE guidelines are diagnosis specific, so the effect of receiving, or not receiving, NICE 
compliant treatment was investigated within diagnostic groupings. In three diagnostic 
groupings sufficient patients (n>100) received treatment that was not compliant with NICE to 
make a comparison between compliant and non-compliant therapy possible. The groupings 
were: Depressive episode, Mixed Anxiety and Depressive Disorder (MADD) and 
Generalised Anxiety Disorder (GAD).  
Logistic regression was also used to identify patient level and service level variables 
that predict reliable recovery. A backwards-stepwise method using the likelihood ratio was 
chosen as this avoids suppressive effects, and is recommended when there are no firm 
hypotheses (Menard, 1995). The variables initially entered in the model are shown in Table 1. 
A liberal criterion for selection was used (α=.2) based on the findings that conservative 
criteria for selection in regression analyses can lead to type II errors (Mickey and Greenland, 
1989). Hosmer and Lemeshow’s test was used to assess the goodness of fit of the models 
(Lemeshow and Hosmer, 1982).  
Logistic regression analyses describe the effects of variables in terms of odds ratios. 
When the independent variable is dichotomous and denotes when a particular event has 
occurred (for example, a patient was self referred) the odds ratio is the ratio of the likelihood 
an event occurring in one group (self referred patients) over the odds of it occurring in the 
other group (non-self referred patients). When the independent variable is continuous, the 
odds ratio describes the increase in likelihood of a patient reliably recovering if there is a 
single unit increase from the mean in the independent variable i.e. if the number of sessions 
of treatment was found to be a significant predictor and have an odds ratio of 1.1, then for 
every extra session above the mean there would be a 10% increase in the likelihood of 
reliable recovery. These odds ratios were considered in a multivariate analysis to control for 
all other variables in the model. 
 
 
Results 
 
Reliable recovery, reliable improvement, and reliable deterioration 
Overall, 40.3% of the 19,395 patients included in the full sample showed reliable recovery.
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However, reliable recovery rates varied considerably from service to service, ranging from a 
low of 23.9% to a high of 56.5% (SD=8.0%). This can be seen in Figure 2.  
Table 2 shows the reliable improvement and reliable deterioration rates. Overall, 
63.7% of patients showed reliable improvement on the combination of PHQ-9 and GAD-7. 
As with the reliable recovery, the rates varied substantially between services, with the lowest 
being 43.6% and the highest being 77.1% (SD=7.1%). Psychological therapies can be 
                                                     
1
 A small number of patients (n=411, 2.1%) finished treatment below the clinical threshold on both the PHQ-9 
and the GAD-7, but did not show reliable improvement either of these measures. 
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harmful as well as helpful. For this reason it is important to determine how many patients 
deteriorate during the course of treatment. Overall, 6.6% of patients showed reliable 
deterioration. Again there was considerable between service variability, with the lowest being 
2.1% and the highest being 11.4% (SD=1.7%). There was a significant negative correlation 
between service reliable improvement rates and service reliable deterioration rates (r=-.397, 
p=. 027), indicating that services in which fewer people improved had a greater proportion 
who deteriorated. 
The analyses above required patients to be cases at the start of treatment. However, a 
number of patients (n=3,759) started treatment below caseness, but were still seen at least 
twice, received some treatment, and had two scores on the PHQ-9 and the GAD-7. The 
proportion of these patients who showed reliable improvement was 24.3% (n=909) and the 
proportion of these patients who showed reliable deterioration was 11.7% (n=439). Further 
investigation showed that 1,024 of these patients could not show reliable improvement, as 
their initial scores on the PHQ-9 and GAD-7 were too low to do so (below 6 and 4, 
respectively). Once this has been taken into account we can see that, of the below caseness 
patients that could show reliable improvement, 33.2% did. 
 
The effect of NICE compliance on reliable recovery 
High intensity therapies. NICE recommends CBT as a high intensity therapy for depression 
and for all anxiety disorders. In the first year of the IAPT programme, the vast majority of 
patients were offered CBT. However, a substantial subset of patients with ICD-10 diagnoses 
of depressive episode, generalized anxiety disorder (GAD) or mixed anxiety and depressive 
disorder (MADD) received counselling. While NICE recommends counselling as well as 
CBT for mild to moderate depression, it does not recommend counselling for GAD. NICE 
have not released any guidance for MADD, which is technically reserved for patients with 
sub-threshold symptoms of anxiety and depression. However, IAPT patients diagnosed with 
MADD had high initial scores on the PHQ-9 (mean =16.33, SD=5.43) and the GAD-7 (mean 
= 14.42, SD=4.41), suggesting that many were probably best considered as individuals with 
both an anxiety disorder and a depressive disorder. For such individuals, current NICE 
guidelines would favour CBT.  
To determine whether compliance with NICE guidance is associated with improved 
clinical outcomes, we compared the raw reliable recovery rates associated with CBT and 
counselling in patients with depressive episodes, GAD and MADD and also used logistic 
regression to control for initial symptom levels and any prior history of low intensity 
intervention. The reliable recovery rates for patients who received high intensity treatment 
and were diagnosed with a depressive episode (unadjusted for any differences in pre-
treatment scores on the PHQ-9 and GAD-7) were 40.0% for those who received CBT 
(n=935) and 38.3% for those who received counselling (n=679). For patients diagnosed with 
GAD the reliable recovery rates were 54.2% for those who received CBT (n=679) and 39.7% 
for those who received counselling (n=302). For patients diagnosed with MADD, the 
respective reliable recovery rates were 39.2% (of 704 patients) and 34.4% (of 1,005 patients).  
Logistic regression analyses (see Table 3) confirmed that compliance with NICE 
guidance was associated with higher recovery rates. Among patients who were diagnosed 
with a depressive episode, those who received CBT were no more or less likely to reliably 
recover than those who received counselling (p=.28). In contrast, among patients diagnosed 
with GAD, those who received CBT were 1.324 times more likely to reliably recover than 
those who received counselling (p< .001). Similarly, among patients who were diagnosed 
with MADD, patients who received CBT were 1.689 times more likely to reliably recover 
(p<.001). In all three logistic regression models, the data were shown to fit the model using 
the Hosmer and Lemeshow test (p>.05). The model for patients with a depressive episode 
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explained 8.4% of the variance (using Nagelkerke’s R2), and the model for patients with 
MADD, 6.6% and GAD, 10.7%. All models were significantly better at predicting patients’ 
outcomes than a model than just contained a constant (p<.001). 
Low intensity therapies. Self-help interventions can be offered with or without the 
guidance of a clinician. NICE guidelines for depression (NICE 2004b, 2009a) recommend 
guided self-help but not pure (non-guided) self-help. At the time of the data collection for this 
paper, NICE (2004a) recommended self-help for the treatment of GAD but did not mention 
the distinction between guided and non-guided delivery. However, in a recent revision to the 
GAD guideline (NICE, 2011a) guided self-help and pure self-help were both recommended, 
although it was acknowledged that the evidence base for pure self-help was modest.  
In the year one IAPT services, the majority of patients who received low intensity 
interventions were given guided self-help. However, a significant sub-group had pure self-
help so it was possible to assess whether compliance with NICE recommendations for low 
intensity treatment was also associated with enhanced reliable recovery rates. The reliable 
recovery rates for patients who received low intensity treatment and were diagnosed with a 
depressive episode (unadjusted for any differences in pre treatment scores on the PHQ-9 and 
GAD-7) were 38.4% for those who received guided self help (n=408) and 27.6% for those 
who received counselling (n=199). For patients diagnosed with MADD, the respective 
reliable recovery rates were 35.3% (of 388) and 35.4% (of 192) and for patients diagnosed 
with GAD the reliable recovery rates were 54.1% (of 279) and 52.3% (of 151).  
Logistic regression analyses showed that among patients who were diagnosed with a 
depressive episode, those who received guided self-help were 1.561 times more likely to 
reliably recover than those who received pure self-help [Wald statistic (1) = 5.239, p= .022, 
Odds ratio = 1.561, Lower CI = 1.066, Upper CI = 2.285]. Among patients who were 
diagnosed with MADD and GAD, they were no more likely to reliably recover if they 
received pure or guided self-help. For patients with MADD the Wald statistic was 0.011 (p= 
.917, Odds ratio = 1.020, Lower CI = 0.698, Upper CI = 1.492). For patients with GAD the 
Wald statistic was 0.013 (p= .908, Odds ratio = 1.025, Lower CI = 0.670, Upper CI = 1.569). 
In all three logistic regression models, the data were shown to fit the model using the Hosmer 
and Lemeshow test (p>.05) and all models were significantly better at predicting patients’ 
outcomes than a model than just contained a constant (p<.05). The model for patients with a 
depressive episode explained 10.5% of the variance (shown by Nagelkerke’s R2), the model 
for patients with MADD, 11.8% and the model for patients diagnosed with GAD explained 
15.6 % of the variance.  
For patients to be included in the analyses above they were required to have evidence 
that they attended IAPT services at least twice. However, some patients were provided with 
self-help materials in session one and were not seen again. We suspected this might be more 
common for people allocated to pure self-help than for people allocated to guided self-help. 
Further analysis confirmed that this was the case. Patients who received pure self-help were 
significantly less likely to have two sets of PHQ-9 and GAD-7 scores than patients who 
received guided self-help [X²(1) =1024.40, p<.001, Φ=.393]. Clearly, we cannot know the 
outcome of these patients with any certainty. However, if we make the conservative 
assumption that they are unlikely to have benefited and so carry forward their session one 
score, the relative reliable recovery rates of patients who received guided and pure self-help 
are altered dramatically. This can be seen in Figure 4. Patients who received guided self –
help were more likely to recover than those who received pure self-help. Logistic regression 
models were created to investigate whether patients who received pure self-help were more 
likely to reliably recover than patients who received guided self-help, if the last observation is 
carried forward. In all three logistic regression models, the data were shown to fit the model 
using the Hosmer and Lemeshow test for goodness of fit (p>.05) and all models were 
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significantly better at predicting patients’ outcomes than a model that just contained a 
constant (p<.001). Receiving guided self-help remained a significant predictor of reliable 
recovery among patients with any of the three diagnoses investigated.  
Among patients who were diagnosed with a depressive episode, those who received 
guided self-help (n=637) were 3.19 times more likely to recover than those who received 
pure self help (n=611) (Wald statistic (1) = 45.91, p<.001 Odds ratio = 3.190, Lower CI = 
2.281, Upper CI = 4.462). Among patients with MADD, those who received guided self-help 
(n=556) were 2.595 more likely to recover than those who received pure self-help (n=596) 
(Wald statistic (1) = 32.914, p<.001 Odds ratio = 2.595, Lower CI = 1.873, Upper CI = 
3.594). Finally, for patients diagnosed with GAD, those who received guided self help 
(n=358) were 2.148 times more likely to recover (n=315)(Wald statistic (1)= 19.015, p<.001, 
Odds ratio = 2.148, Lower CI = 1.523, Upper CI = 4.462). 
The model for patients diagnosed with a depressive episode explained 13.0% of the 
variance (shown by Nagelkerke’s R2), the model for patients with MADD, 11.6% and the 
model for patients diagnosed with GAD explained 13.7% of the variance. 
Of all the patients that were stepped up to high intensity intervention after a low 
intensity intervention, a significantly higher proportion had received pure self-help than 
guided self-help [X²(1)=466.09, p<.001, Φ=.287]. The proportion of patients who were 
stepped up after receiving guided self-help was 25.7%, compared to 54.5% of patients who 
received pure self-help. This finding would appear to confirm the inferiority of pure self-help. 
 
Factors predicting reliable recovery 
A logistic regression was used to investigate the patient and service level factors that predict 
reliable recovery. As mentioned earlier, this logistic regression focused on the subset of 
patients (n=11, 535) who had been given an ICD-10 diagnosis by their service and for whom 
the relevant service level variables were available
2
. The reliable recovery rate in this sample 
(40.3%) is essentially the same in the full sample, as were the proportions of patients who 
showed reliable improvement (64.6%) and reliable deterioration (6.8%). The model was 
shown to fit the data well, as Hosmer and Lemeshow’s test was non-significant [X²(8) 
=4.698, p=.789]. Nagelkerke’s R² showed that the model explained 13.2% of the variance. 
The model differed significantly from a model which only included the constant [X²(14) 
=1188.521, p<.001]. The model successfully identified 81.4% of patients who did not 
reliably recover and 41.9% of those who did. Overall, the model correctly identified 65.5% of 
patients’ outcomes. Table 1 shows the patient and service level variables that were 
investigated and Table 4 shows those variables that were significant predictors of reliable 
recovery.  
 
Patient level variables 
Initial Severity: Patients’ initial PHQ-9 and GAD-7 scores had a significant effect on reliable 
recovery. Patients with higher initial scores were less likely to reach reliably recovery. 
However, this does not mean that patients with moderate or severe symptoms benefited less 
from therapy that those with mild symptoms. Indeed there was some evidence to the contrary 
(see Figure 3). Patients were divided into three initial severity groupings (moderate, 
moderately severe or severe) on the basis of published norms (Kroenke et al., 2001). A 
Kruskal Wallis test comparing change scores found that increasing severity was associated 
with greater improvement [X²(2) =457.64, p<.001]. The mean change for patients initially 
classed as having moderate depressive symptomatology on the PHQ-9 was 4.47 (SD=5.35) in 
                                                     
2
Most of the variables that are significant predictors in this logistic regression were also significant in a logistic 
regression that was run on the full sample for sensitivity purposes. However, the model fit was less good, 
perhaps because ICD-10 diagnosis, which is a significant predictor, could not be included.  
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comparison to 7.99 (SD=7.63) for patients with severe depressive symptomatology. The 
same pattern of results was found for patients’ scores on the GAD-7 when patients’ initial 
scores were classed as mild, moderate or severe based on published norms (Spitzer et al., 
2006). The mean change on the GAD-7 for patients initially classed as ‘mild’ on the measure 
was 2.16 (SD=4.32) in comparison to 6.77 (SD=6.27) for patients classed as ‘severe’. All 
groups showed marked improvement with the greatest improvement being shown by the 
patients who started treatment with higher scores [X²(2) = 1244.01, p<.001]. 
Self-referral: Whether or not patients referred themselves to treatment was not a 
predictor of reliable recovery. However, patients who reliably recovered and had self-referred 
had fewer therapy sessions than patients who reliably recovered and were not self-referred 
[Mann-Whitney U=1932729, p=.005, r=.031]. This suggests that the process of self-referral 
may facilitate therapy. 
Treatment received: The model shows that when all things are considered, reliable 
recovery is was less likely if patients received ‘other treatment’ and was more likely if 
patients received high intensity treatment, compared to not receiving these treatments. 
“Other” treatment was a code used when the intervention was not a recognized high or low 
intensity intervention.  
Diagnosis: Patients who were diagnosed with depressive episode, GAD, MADD or 
PTSD were significantly more likely to recover than patients who did not receive these 
diagnoses. 
 
Service level variables 
Use of Stepped Care: Patients treated in services in which a greater proportion of patients 
who received low intensity treatment were stepped up from low intensity to high intensity 
care had higher overall rates of reliable recovery. 
Mean number of therapy sessions: Patients treated in services with higher average 
numbers of therapy sessions were more likely to recover than patients treated in services in 
which fewer sessions were offered. This finding was significant for low intensity therapy and 
for patients who received any high intensity treatment. 
Staff Salary Bands: In the National Health Service (NHS) staff receive remuneration 
based on a national standardised pay-scale. This is negotiated centrally and is organised into 
‘Agenda for Change’ (AfC) bands, which range from Band 1 to Band 9. The distribution of 
staff salary bandings within a service was a significant predictor of reliable recovery. Patients 
treated in services where a greater proportion of therapist sessions were undertaken by 
therapists banded at AfC band 7 or above, were more likely to reliably recover than patients 
treated in services where a smaller proportion of sessions were undertaken by such workers. 
In year one of the IAPT programme most trainee therapists would have been paid below AfC 
Band 7. This finding may therefore indicate that services with a larger cohort of clinically 
active experienced staff achieve higher reliable recovery rates. 
Size of the service: The number of patients treated at a service was found to be an 
important predicting factor in patients’ reliable recovery. The greater the number of patients 
treated at the service, the more likely it was that patients treated at the service would reliably 
recover.  
 
 
Discussion 
 
The English Improving Access to Psychological Therapies (IAPT) initiative is probably the 
world’s largest single programme for disseminating evidence-based psychological therapies 
to a general population. The use of a session-by-session outcome monitoring system has 
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ensured that clinical outcomes are recorded on almost everyone who is treated in the IAPT 
services. This has brought unparalleled public transparency to mental health provision with 
key performance indicators (KPIs) for all IAPT services published every three months on the 
national Health and Social Care Information Centre website 
(http://www.hscic.gov.uk/mentalhealth). The large database also provides an opportunity to 
learn lessons about the way in which psychological therapies might best be provided in order 
to maximize clinical outcomes. This paper, which focuses on data from the first year of the 
programme, is one of the first attempts to identify such lessons. In future years further 
analyses based on the evolving database will be published. The present analyses were 
conducted in close collaboration with the IAPT clinical services. Regional representatives 
suggested questions that could be investigated in the analysis. Several key findings have 
emerged from the analyses that are likely help the local services further develop their 
provision in the future. Many may also be helpful for commissioners and clinicians in other 
countries as they pursue their own plans to increase the availability of evidence-based 
psychological therapies for their own populations. 
 
Key performance indicators 
Support for the IAPT programme critically depends on it being able to show that it can 
achieve the kind of results one might expect from published randomized controlled trials of 
psychological therapies. For this reason, IAPT services were all asked to report a simple 
measure of outcome from the beginning of the initiative. The measure was “recovery”, which 
was judged to have occurred if a patient scored above the clinical cut-off on the PHQ-9 
and/or the GAD-7 at pre-treatment and scored below the clinical cut-off on both at discharge 
from the service. This measure, which we will term the recovery index is easy to calculate 
and has served the programme well. However, it has several limitations.  
First, the recovery index does not take into account the measurement error associated 
with each scale so it is possible that some mild cases will be classified as recovered when the 
observed symptom reduction is not reliable. To get round this problem, we used a modified, 
reliable recovery index (RRI) in our analyses and recommend that it is used in the future. 
Encouragingly, the overall findings with the reliable recovery index (40.3% of patients 
classified as recovered) are not much different from those for the original recovery index 
(42.4 % of patients classified as recovered). However, it is possible that in some services the 
difference will be larger and it would be important to know this.  
Second, the binary nature of the recovery index means that no information is provided 
on the improvements that patients who did not fully recover may have made during 
treatment. It was suspected that many patients who had not fully recovered might still have 
made worthwhile gains. The adoption of a reliable improvement measure has demonstrated 
that is in fact what happened. While 40.3% of patients who were initial cases showed reliable 
recovery, 63.7% showed reliable improvement. 
Third, the recovery index provides no information about deterioration. Psychological 
therapies have the potential to do harm as well as good. Given this point, it is important to 
assess the extent to which patients may get worse during a course of therapy. The reliable 
deterioration measure reported here indicated that 6.6% of patients got worse during their 
treatment in IAPT services. This overall rate is probably less than one would observe in a 
population allocated to a wait-list and so is probably not a cause for concern. However, it 
may be higher in some services and it should be carefully monitored in the future. Services 
may also wish to conduct their own audits of individuals who show reliable deterioration in 
order to identify any patterns (particular subsets of individuals, therapists, or treatments) that 
can inform further service development.  
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Finally, the main logistic regression found that RRI rates were highest in patients who 
had an ICD-10 diagnosis of depressive episode, GAD, MADD or PTSD. It is unclear how 
one should interpret this finding. It may mean that people with these conditions show greatest 
benefit from IAPT treatment. However, it could also be an artifact of unknown variation in 
natural recovery rates or a quirk of the measurement system used in year one. In connection 
with the latter, the PHQ-9 and the GAD-7 are sensitive measures for detecting and assessing 
change in depression and GAD but are less sensitive for other anxiety disorders, such as 
social anxiety disorder and obsessive-compulsive disorder. A revised IAPT minimum dataset 
has now been published (Department of Health, 2011) which includes sensitive measures of 
these conditions so future analyses will be able to investigate this issue.  
 
Importance of compliance with NICE’s recommendations for treatment types 
A defining feature of the IAPT programme is that it aims to greatly increase the availability 
of NICE recommended psychological therapies for anxiety disorders and depression 
(Department of Health, 2008). In line with this aim, most of the patients treated in the first 
year of the programme received a NICE recommended treatment. However, for three 
disorders (depression, generalized anxiety disorder, mixed anxiety and depressive disorder) a 
significant minority received an intervention that is not recommended by NICE. This created 
a natural experiment in which it was possible to assess whether deviation from NICE 
guidelines was associated with reduced reliable recovery rates. The main analysis of the 
importance of compliance with NICE guidance focused on individuals who had been 
ascribed an ICD-10 diagnosis by their service, as NICE guidelines are diagnosis specific.  
When considering high intensity treatments, NICE (2005a, 2005b, 2009a, 2011a, 
2013) recommends both CBT and counseling for mild to moderate depression but only 
recommends CBT for any of the anxiety disorders. The observed results were in line with 
these recommendations. In particular, CBT and counseling were associated with similar 
reliable recovery rates in depression but CBT was associated with significantly higher 
reliable recovery rates than counseling in generalized anxiety disorder (GAD) and in mixed 
anxiety and depressive disorder (MADD). In depression, there was no difference in recovery 
rates between CBT and counseling. However in GAD and MADD patients who received 
CBT were more likely to recover than those who received counseling.  
Turning to low intensity treatment, for depression NICE (2004b,2009a) recommends 
guided self-help but not pure self-help. The observed results were in line with this 
recommendation. Reliable recovery rates were significantly higher among those who 
received guided self-help than among those who received pure self-help. The same pattern 
was also observed among patients with MADD. For GAD, NICE guidelines are less clear. 
The original guideline (NICE 2004b) failed to distinguish between guided and pure self-help 
and the revised guideline (2011a) recommends both, while acknowledging that the evidence 
base for pure self-help is modest. Our findings are similarly unclear. If one looks at those 
individuals with GAD who were seen at least twice in the services, there is no difference in 
reliable recovery rates between guided and pure self-help. However, a significantly greater 
proportion of people who were given pure self-help were only seen once. We cannot know 
how these people faired but if one assumes no benefit, then the overall reliable recovery rate 
is significantly lower for pure self-help than guided self-help. This result raises concern about 
the use of pure self-help in GAD and, at the least, suggests that if services choose to use pure 
self-help, they should give patients a follow-up appointment to assess whether any benefit 
has occurred and to move patients onto an assisted, low or high intensity treatment if there is 
no improvement. 
A further indication of the importance of compliance with NICE guidance concerns 
the findings with respect to “other” treatment in the logistic regression that included patients 
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who had not been given an ICD-10 diagnosis as well as those for whom a diagnosis was 
available. The “other” category was reserved for treatments that were not in the list of 
treatments that would be recommended by NICE for any of the disorders covered by the 
IAPT programme. In line with NICE’s recommendations, “other” treatment was associated 
with a lower overall reliable recovery rate. 
The comparisons above between NICE compliant and non-compliant treatments are 
naturalistic. The logistic regressions controlled for initial severity. However, as patients were 
not randomized to the different types of treatment it is always possible that there some 
unobserved, but systematic differences between individuals who received the NICE 
complaint and non-compliant treatments were present. Given this point, it would be wrong to 
take our findings as a demonstration of efficacy per se. Instead they simply indicate that 
when one looks at treatments naturalistically deployed in the field, the pattern of results that 
is obtained is largely in line with what one might expect given NICE guidance.  
As the IAPT programme has developed it has expanded patient choice among NICE 
recommended treatments for depression. In addition to counseling, couples therapy, 
interpersonal psychotherapy and brief psychodynamic therapy are all now available in some 
IAPT services and it is estimated by the Department of Health (2013) that around 30% of 
IAPT high intensity therapists are able to deliver these non-CBT treatments. Future analyses 
of IAPT databases will no doubt investigate whether these different treatments are associated 
with similar outcomes among depressed patients. 
 
Patient and service level predictors of reliable recovery 
Several patient and service level variables were found to be significant predictors of reliable 
recovery.  
Initial severity: Patients whose initial symptom severity is moderate to severe need to 
show considerably more symptomatic improvement than patients with mild to moderate 
symptoms in order to be classified as reliably recovered. Given this point, it is perhaps not 
surprising that initial severity predicted reliable recovery. However, analysis of continuous 
change scores indicated that patients with more severe symptoms showed as much, indeed 
slightly more, symptomatic improvement than those with mild symptoms. The greater change 
in more severe patients may be regression to the mean. However, the fact that substantial 
change was shown at all levels of initial severity suggests that IAPT services benefit patients 
over the full range of severity. It also raises the question of whether in the future the key 
performance indicators should be expanded to include an index that more accurately captures 
the amount of improvement that a patient makes independent of start level. Pre-treatment to 
post-treatment effect size would seem an obvious candidate.  
Self-referral: Traditionally the English NHS has restricted access to specialist 
services to individuals who are referred by their general practitioner (GP). However, the 
IAPT programme allows self-referral because there was concern that some patients with 
depression and/or anxiety disorders may be reluctant to contact their GP in the first place 
(Department of Health, 2008) and one of the pilot sites (Newham) found that individuals 
from the black and ethnic minority community and some anxiety disorders were under-
represented in GP referrals (Clark et al., 2009). As in the analysis of the original pilot sites 
(Clark et al., 2009), patients who were treated in the first year of the national roll-out did not 
differ in their recovery rates as a function of how they were referred. However, it is 
interesting to note that self-referred patients who showed reliable recovery had received less 
treatment sessions than GP referred patients who also achieved reliable recovery. 
Anecdotally, it seems that self-referred patients are more likely to have sought out detailed 
information about the services (from websites, leaflets etc.) in advance of their first 
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appointment. This may help ensure that they are more engaged in treatment from the start. 
Further research could helpfully explore this possibility. 
Use of stepped care: Stepped care is at the heart of the IAPT clinical model. With the 
exception of patients with PTSD or social anxiety disorder, it is suggested that patients with 
mild to moderate symptoms of depression or other anxiety disorders could be offered low 
intensity (such as guided self-help) interventions initially, with patients who fail to recover at 
that level being stepped up to high intensity intervention (Department of Health, 2010, p32). 
The finding that services that have an overall higher step-up rate also have an overall higher 
reliable recovery rate suggests that it is important that services make full use of their stepped 
care system and encourage patients to continue from low to high intensity work, if 
appropriate. 
Mean number of therapy sessions: In addition to specifying certain types of therapy, 
NICE also provides recommendations about the number of therapy sessions that patients 
should be offered. In general, it is recommended that patients should be offered up to the 
number of sessions provided in the randomized controlled trials that generated the relevant 
NICE guideline. For high intensity treatments this would generally be in the range of 12-20 
sessions, depending on diagnosis and severity. Our finding that services that offered higher 
mean numbers of low intensity and high intensity treatment sessions had overall higher 
recovery rates would seem to support NICE’s position.  
Staff salary bands: IAPT aims to increase access to evidence-based psychological 
therapies by expanding the work-force that is trained to deliver such treatments. In the first 
year, most of the staff in the service were still in training. The Department of Health (2008) 
recommended that IAPT services should have a core of at least a third of their staff who were 
already fully trained in order to provide supervision to trainees and treat the more complex 
cases themselves. The finding that overall rates of reliable recovery were higher in services in 
which a larger number of therapy sessions were provided by staff in salary bands (AfC7 or 
above) that are usually reserved for experienced staff would appear to support this 
recommendation. If this is the correct interpretation of the finding, the relationship between a 
service’s distribution of salary bands and its overall reliable recovery rate may change in 
future years as services increase the number of fully trained low intensity workers that they 
employ. This is because fully trained low intensity workers would normally be employed at 
AfC 5 or 6.  
Size of the service: The average number of patients treated per day in a service was 
related to the overall outcome. Services that treated larger numbers of patients had higher 
overall reliable recovery rates. At this stage it is unclear how to interpret this finding. One 
possibility is that, on average, higher volume services have more clearly developed 
organizational procedures (including supervision protocols) and had more practice with the 
IAPT model. However, there were no direct measures of these concepts and further research 
is required to clarify the benefits of larger services. 
 
Limitations 
This study has a number of limitations, most obviously that it was not a controlled 
experiment, and therefore the results should not be treated as such. However, the study does 
allow us to see whether the results from randomized controlled trials can be implemented in 
routine care on a national scale and to identify what factors in that routine care might affect 
outcome. A limitation to the analysis of variation between services was that the service 
variables were derived from patient level variables. This method has an advantage as it 
creates a composite picture of the service over the course of a year. However, it is also a 
disadvantage as the analyses treat operationally dynamic variables as static across the period 
of a year. Services may have changed their policies over the course of the year, as services’ 
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policies change over time a better understanding of the impact in varying services’ policies 
may be gained. Although IAPT services were good at collecting session by session outcome 
data, they were less good at giving patients’ provisional diagnoses. This limited the sample 
used in the predictor analyses. However, sensitivity analyses conducted to investigate 
whether the patient and service level factors that predicted improved reliable recovery rates 
generalised to the full sample that included patients who had not received a diagnosis suggest 
that the sample restriction was not a serious problem.  
 
Implications for practice 
The study has two broad implications for the design and management of routine 
psychological therapy services. First, the use of a session by session outcome monitoring 
system made it possible to obtain high levels of pre-treatment to post-treatment data 
completeness (over 91% of cases). High levels of data completeness are important as in a 
previous study of a routine service (Clark et al. 2009) we found that patients who failed to 
provide post-treatment outcome data tended to have done less well. Adopting a session-by-
session outcome monitoring system might enable services with low data completeness rates 
to improve their completeness rates and so obtain a more accurate picture of the benefits of 
the service that they provide. Second, the patient and service level characteristics that 
predicted higher reliable recovery rates in our study are generally consistent with NICE 
recommendations and the IAPT model, some aspects of which may be of interest to policy 
makers, commissioners and clinicians in other countries as they strive to improve access to 
psychological therapies within their own healthcare systems. Further information on the 
IAPT programme, including its recommended quality standards for psychological therapy 
services can be found on the IAPT website (www.iapt.nhs.uk).  
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Table 1. Possible predictors of reliable recovery included in the logistic regression  
 
 
 
 
                                                     
3
 The effect, if any, of therapist salary banding on patient recovery was investigated using the logistic regression 
model. In order to do this, some preliminary analysis was required to determine the most appropriate cutting 
point. We calculated the relationship between the overall reliable recovery rates for services and the proportion 
of therapy sessions that were delivered by therapists at Agenda for Change band X and above, where X ranged 
from 4 to 8d (the highest banding a clinician in IAPT services could have). The strongest relationship in this 
sample was observed when X was 7, so this was chosen as the Agenda for Change cutting point for the logistic 
regression analysis. 
 
Patient Level Variables Service Level Variables 
Initial PHQ-9 scores  Service Salary Banding Distribution
3
  
Initial GAD-7 scores  Service Self-Referral  
Whether or not patients were self-referred  The median number of sessions given by the 
service to patients who received low 
intensity treatment only 
Whether the patient received the low 
intensity therapy  
The median number of sessions given by the 
service to patients who received high 
intensity treatment either on its own or after 
receiving low intensity treatment 
Whether the patient received the high 
intensity therapy  
Service Size (The number of patients treated 
at the service divided by the length of time a 
service was operating for.)
 
 
Whether the patient received both low and 
high intensity therapy  
Proportion of patients who received low 
intensity treatment who also received high 
intensity  
Whether the patient received ‘other 
treatment’ 
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Table 2. The proportions of the patients who showed reliable deterioration, no reliable 
change or reliable improvement on the PHQ-9 and the GAD-7  
 
Reliable Change Measured on GAD-7 
Reliable 
Deterioration 
No Reliable 
Change 
Reliable 
Improvement 
Reliable 
Change 
Measured on 
the PHQ-9 
Reliable 
Deterioration 
1.2% (n=241) 1.7% (n=337) 0.2% (n=44) 
No Reliable 
Change 
3.7% (n=711) 
29.0% 
(n=5,617) 
16.8% 
(n=3,262) 
Reliable 
Improvement 
0.4% (n=84) 7.5%(n=1,445) 
39.5% 
(n=7,654) 
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Table 3. Summary of logistic regression models investigating whether receiving CBT or 
counselling has an impact on patients’ likelihood of reliable recovery 
Diagnosis 
Group 
Variable B S.E. Wald Sig. Odds 
Ratio 
95% C.I. for Odds 
ratio 
Lower Upper 
Depressive 
Episode 
Initial PHQ-9 Scores -0.073 0.012 36.38 <.001 0.929 0.907 0.952 
Initial GAD-7 Scores -0.048 0.013 13.488 <.001 0.953 0.929 0.978 
Patient was Stepped 
Up 
-0.183 0.106 2.99 0.084 0.833 0.677 1.025 
Patient received CBT 
(in comparison to 
patients who received 
counselling) 
0.116 0.107 1.177 0.278 1.124 0.91 1.387 
Constant 1.271 0.205 38.639 <.001 3.566   
MADD 
Initial PHQ-9 Scores -0.055 0.011 24.316 <.001 0.947 0.927 0.968 
Initial GAD-7 Scores -0.046 0.014 10.578 0.001 0.956 0.93 0.982 
Patient was Stepped 
Up 
0.186 0.104 3.164 0.075 1.204 0.981 1.478 
Patient received CBT 
(in comparison to 
patients who received 
counselling) 
0.281 0.106 6.973 0.008 1.324 1.075 1.632 
Constant 0.942 0.198 22.598 <.001 2.564   
GAD 
Initial PHQ-9 Scores -0.067 0.013 26.485 <.001 0.935 0.912 0.959 
Initial GAD-7 Scores -0.055 0.018 9.831 0.002 0.947 0.915 0.98 
Patient was Stepped 
Up 
0.186 0.104 3.164 0.075 1.204 0.981 1.478 
Patient received CBT 
(in comparison to 
patients who received 
counselling) 
0.524 0.149 12.377 <.001 1.689 1.261 2.263 
Constant 1.303 0.262 24.758 <.001 3.68   
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Table 4. Variables included in the model after stepwise removal 
 Variable B S.E. Wald Sig. Odds 
ratio 
 
95% C.I. for 
Odds ratio 
       Lower Upper 
Patient Level Variables 
Initial PHQ-9 Scores -0.08 0.004 342.90
4 
<.001 0.923 0.915 0.931 
Initial GAD-7 Scores -0.047 0.005 82.125 <.001 0.954 0.945 0.964 
Patient received high 
intensity treatment 
0.109 0.046 5.553 0.018 1.116 1.019 1.222 
Patient received 'other 
treatment' 
-0.393 0.135 8.445 0.004 0.675 0.518 0.88 
Depressive Episode 
Diagnosis 
0.184 0.068 7.277 0.007 1.202 1.052 1.373 
MADD Diagnosis 0.146 0.068 4.599 0.032 1.157 1.013 1.322 
GAD Diagnosis 0.369 0.074 25.023 <.001 1.447 1.252 1.672 
Phobias Diagnosis 0.167 0.109 2.352 0.125 1.182 0.955 1.463 
PTSD Diagnosis 0.381 0.158 5.837 0.016 1.464 1.075 1.995 
Service Level Variables 
Step Up Rate 1.074 0.128 70.603 <.001 2.926 2.278 3.758 
Median number of 
sessions given to 
patients who received 
low intensity treatment 
0.186 0.027 47.938 <.001 1.204 1.142 1.269 
Median number of 
sessions given to 
patients who received 
high intensity (either 
alone or after being 
stepped up) 
0.069 0.02 12.43 <.001 1.071 1.031 1.113 
Proportion of sessions 
undertaken by 
therapists banded at 
AfC 7 or above 
0.631 0.211 8.945 0.003 1.880 1.243 2.844 
Size of service (Number 
of Patients completing 
treatment at the service 
per day) 
0.162 0.024 47.105 <.001 1.176 1.123 1.231 
Constant -0.499 0.179 7.744 0.005 0.607   
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Figure 1. Cohort used in the analyses 
79,310 
Had an assessment 
 
 
  
 
 
 37,586 patients listed as still being in the 
system or did not have treatment end 
marker 
41,724 
Listed as no longer in IAPT services 
 
 
  
 
 
 
1,905 patients listed as not having received 
treatment 
39,819 
Listed as receiving some treatment 
 
 
  
 
 
 
7,437 patients were not a case at 
assessment 
32,382 
Were cases at assessment 
 
 
  
 
 10,500 patients had no evidence of having 
more than one contact with an IAPT service. 
Many were probably signposted elsewhere. 
21,882 
Had evidence of having more than one 
contact with an IAPT service 
 
 
  
 
 
 1,873 patients did not have two complete 
sets of outcome data for the PHQ-9 and 
GAD-7 
20,009 
Had two complete sets of outcome data for 
the PHQ-9 and GAD-7 
 
 
  
 
 
 
614 patients were listed as unsuitable or 
declined and had no more than 2 sessions 
19,395 
Cohort Used in Analyses when service level 
data and ICD-10 codes were not required 
 
 
 
 
 
 
7,142 patients did not have an ICD-10 code  
 718 did not have sufficient service data  
11,535 
Cohort used in the logistic regression 
investigating the factors which predict 
reliable recovery 
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Figure 2. Variability in service reliable recovery rates 
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Figure 3. Change in PHQ-9 scores as a function of initial severity 
 
 
Figure 4. Comparison of Reliable Recovery Rates between patients who received guided 
and pure self-help by diagnosis among patients whose last scores on the PHQ-9 and 
GAD-7 scores are carried forward 
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